Risk of Early Versus Late Recurrence

Hope S. Rugo, MD, and Ruth O’Regan, MD, describe the factors that increase the risk of late recurrence, and the tumor characteristics defining who can forego extended adjuvant aromatase inhibitor therapy in breast cancer.